Literature DB >> 25758610

Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.

Arun Z Thomas1, Mehrad Adibi1, Leonardo D Borregales1, Ly N Hoang1, Pheroze Tamboli2, Eric Jonasch3, Nizar M Tannir3, Surena F Matin1, Christopher G Wood1, Jose A Karam4.   

Abstract

PURPOSE: Isolated local retroperitoneal recurrence after radical nephrectomy for renal cell carcinoma poses a therapeutic challenge. We investigated outcomes in patients with localized retroperitoneal recurrence treated with surgical resection.
MATERIALS AND METHODS: This was a retrospective, single institutional study of 102 patients with retroperitoneal recurrence treated with surgery from 1990 to 2014. Demographics, clinical and pathological features, location of retroperitoneal recurrence and perioperative complications are reported using descriptive statistics. We studied recurrence-free and cancer specific survival using univariate and multivariate analyses.
RESULTS: Median age at retroperitoneal recurrence diagnosis was 55 years (IQR 49-64). Cancer was pT3-4 in 62 patients (60.8%) and pN1 in 20 (19.6%). No patients had distant metastatic disease at retroperitoneal recurrence surgery. Median time from nephrectomy to retroperitoneal recurrence diagnosis was 19 months (IQR 5-38.8). The median size of the resected retroperitoneal recurrence was 4.5 cm (IQR 2.7-7). Median followup after recurrence surgery was 32 months (IQR 16-57). Metastatic progression was observed in 60 patients (58.8%) postoperatively. Neoadjuvant and salvage systemic therapy was administered in 46 (45.1%) and 48 patients (47.1%), respectively. On multivariate analysis pathological nodal stage at original nephrectomy and maximum diameter of retroperitoneal recurrence were identified as independent risk factors for cancer specific death.
CONCLUSIONS: Clinicopathological factors at nephrectomy as well as retroperitoneal recurrence surgery are important prognosticators. Aggressive surgical resection offers potential cure in a substantial number of patients with retroperitoneal recurrence with acceptable complications and still has a dominant role in the management of isolated locally recurrent RCC.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  carcinoma; kidney; local; lymph nodes; neoplasm recurrence; nephrectomy; renal cell

Mesh:

Year:  2015        PMID: 25758610      PMCID: PMC4666307          DOI: 10.1016/j.juro.2015.02.2943

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

Review 1.  The changing natural history of renal cell carcinoma.

Authors:  A J Pantuck; A Zisman; A S Belldegrun
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

2.  Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study.

Authors:  Philippe Paparel; Pierre Bigot; Xavier Matillon; Karim Bensalah; Laurent Salomon; Hervé Baumert; Cyril Bastide; Rodolphe Thuret; Gilles Karsenty; Jean Alexandre Long; Myriam Ammi; Thomas Bessede; Sylvie Bin; Adeline Roux; Bernard Escudier; Nathalie Rioux Leclercq; Géraldine Pignot; Michel Soulie; Jean-Jacques Patard
Journal:  J Surg Oncol       Date:  2013-10-30       Impact factor: 3.454

3.  Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.

Authors:  Jithin Yohannan; Tom Feng; Jared Berkowitz; Stephen S Connolly; Philip Pierorazio; Mohamad E Allaf
Journal:  J Endourol       Date:  2010-10       Impact factor: 2.942

4.  Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.

Authors:  Steffen Schrodter; Oliver W Hakenberg; Andreas Manseck; Steffen Leike; Manfred P Wirth
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

5.  Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

Authors:  N B Itano; M L Blute; B Spotts; H Zincke
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

6.  Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma.

Authors:  E Jason Abel; Jose A Karam; Alonso Carrasco; Surena F Matin
Journal:  J Endourol       Date:  2011-07-20       Impact factor: 2.942

7.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

8.  Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort.

Authors:  Christopher M Russell; Patrick N Espiritu; Wassim Kassouf; Thomas Schwaab; David D Buethe; Jasreman Dhilon; Wade J Sexton; Michael Poch; Julio M Powsang; Simon Tanguay; Madhur Nayan; Hazem Alsaadi; Michael I Hanzly; Philippe E Spiess
Journal:  J Urol       Date:  2014-02-14       Impact factor: 7.450

Review 9.  Metastatic renal cell carcinoma: recent advances in the targeted therapy era.

Authors:  Giuseppe Di Lorenzo; Riccardo Autorino; Cora N Sternberg
Journal:  Eur Urol       Date:  2009-09-08       Impact factor: 20.096

10.  Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.

Authors:  Cora N Sternberg; Ian D Davis; Jozef Mardiak; Cezary Szczylik; Eunsik Lee; John Wagstaff; Carlos H Barrios; Pamela Salman; Oleg A Gladkov; Alexander Kavina; Juan J Zarbá; Mei Chen; Lauren McCann; Lini Pandite; Debasish F Roychowdhury; Robert E Hawkins
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

View more
  12 in total

1.  Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Authors:  Wassim Kassouf; Leonardo L Monteiro; Darrel E Drachenberg; Adrian S Fairey; Antonio Finelli; Anil Kapoor; Jean-Baptiste Lattouf; Michael J Leveridge; Nicholas E Power; Frederic Pouliot; Ricardo A Rendon; Robert Sabbagh; Alan I So; Simon Tanguay; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-05-31       Impact factor: 1.862

2.  Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma.

Authors:  Paolo Capogrosso; Alessandro Larcher; Daniel D Sjoberg; Emily A Vertosick; Francesco Cianflone; Paolo Dell'Oglio; Cristina Carenzi; Andrea Salonia; Andrew J Vickers; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  J Urol       Date:  2018-01-31       Impact factor: 7.450

3.  The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.

Authors:  Arun Z Thomas; Mehrad Adibi; Rebecca S Slack; Leonardo D Borregales; Megan M Merrill; Pheroze Tamboli; Kanishka Sircar; Eric Jonasch; Nizar M Tannir; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  J Urol       Date:  2016-03-29       Impact factor: 7.450

4.  Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.

Authors:  Bernhard Brehmer; Caroline Kauffmann; Christian Blank; Axel Heidenreich; Axel Bex
Journal:  World J Urol       Date:  2016-06-10       Impact factor: 4.226

5.  Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound?

Authors:  Mark Quinlan; Gavin Wei; Niall Davis; Cedric Poyet; Marlon Perera; Damien Bolton; Nathan Lawrentschuk
Journal:  Curr Urol       Date:  2019-09-10

6.  Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.

Authors:  Paras H Shah; Daniel M Moreira; Zhamshid Okhunov; Vinay R Patel; Sameer Chopra; Aria A Razmaria; Manaf Alom; Arvin K George; Oksana Yaskiv; Michael J Schwartz; Mihir Desai; Manish A Vira; Lee Richstone; Jaime Landman; Arieh L Shalhav; Inderbir Gill; Louis R Kavoussi
Journal:  J Urol       Date:  2016-02-19       Impact factor: 7.600

Review 7.  Surgical Management of Local Recurrences of Renal Cell Carcinoma.

Authors:  Ömer Acar; Öner Şanlı
Journal:  Surg Res Pract       Date:  2016-01-26

8.  Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.

Authors:  Qingchun Li; Yuan Tian; Guangrui Hu; Yun Liang; Wei Bai; Hongjun Li
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

9.  Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohort.

Authors:  Michele Marchioni; Petros Sountoulides; Maria Furlan; Maria Carmen Mir; Lucia Aretano; Jose Rubio-Briones; Mario Alvarez-Maestro; Marta Di Nicola; Alfredo Aguilera Bazán; Alessandro Antonelli; Claudio Simeone; Luigi Schips
Journal:  Int Urol Nephrol       Date:  2021-08-21       Impact factor: 2.370

10.  A tumoral mass (local recurrence of renal cell carcinoma) causing massive intraabdominal bleeding after blunt abdominal trauma.

Authors:  İhsan Yıldız; Yavuz Savaş Koca; Koray Okur; İbrahim Barut
Journal:  Int J Surg Case Rep       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.